Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3764836
Max Phase: Preclinical
Molecular Formula: C36H36F3N3O2
Molecular Weight: 599.70
Molecule Type: Small molecule
Associated Items:
ID: ALA3764836
Max Phase: Preclinical
Molecular Formula: C36H36F3N3O2
Molecular Weight: 599.70
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(N[C@@H](CCCCNC1CC1c1ccccc1)C(=O)NCc1cccc(C(F)(F)F)c1)c1ccc(-c2ccccc2)cc1
Standard InChI: InChI=1S/C36H36F3N3O2/c37-36(38,39)30-15-9-10-25(22-30)24-41-35(44)32(16-7-8-21-40-33-23-31(33)28-13-5-2-6-14-28)42-34(43)29-19-17-27(18-20-29)26-11-3-1-4-12-26/h1-6,9-15,17-20,22,31-33,40H,7-8,16,21,23-24H2,(H,41,44)(H,42,43)/t31?,32-,33?/m0/s1
Standard InChI Key: SVRXJVGEJNTFDZ-OMYKBPHGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 599.70 | Molecular Weight (Monoisotopic): 599.2760 | AlogP: 7.10 | #Rotatable Bonds: 13 |
Polar Surface Area: 70.23 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.92 | CX Basic pKa: 9.99 | CX LogP: 7.03 | CX LogD: 4.52 |
Aromatic Rings: 4 | Heavy Atoms: 44 | QED Weighted: 0.14 | Np Likeness Score: -0.78 |
1. Kakizawa T, Mizukami T, Itoh Y, Hasegawa M, Sasaki R, Suzuki T.. (2016) Evaluation of phenylcyclopropylamine compounds by enzymatic assay of lysine-specific demethylase 2 in the presence of NPAC peptide., 26 (4): [PMID:26794039] [10.1016/j.bmcl.2016.01.036] |
2. Dai XJ, Liu Y, Xiong XP, Xue LP, Zheng YC, Liu HM.. (2020) Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective., 63 (23.0): [PMID:32931269] [10.1021/acs.jmedchem.0c00919] |
Source(1):